0001447028-20-000027.txt : 20200219 0001447028-20-000027.hdr.sgml : 20200219 20200219080332 ACCESSION NUMBER: 0001447028-20-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200217 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS DAVID C CENTRAL INDEX KEY: 0001237401 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 20627446 MAIL ADDRESS: STREET 1: C/O ARBUTUS BIOPHARMA STREET 2: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 wf-form4_158211739512646.xml FORM 4 X0306 4 2020-02-17 0 0001447028 Arbutus Biopharma Corp ABUS 0001237401 HASTINGS DAVID C C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE WARMINSTER PA 18974 0 1 0 0 Chief Financial Officer Stock Options 3.35 2020-02-17 4 A 0 100000 0 A 2030-02-17 Common Stock 100000.0 100000 D The stock option will vest and become exercisable 1/48th each month over the four year period. /s/ Dave Kille as attorney-in-fact for David C. Hastings 2020-02-19